FEB 20, 2017 10:31 AM PST

New Precious Metal Attacks Cancer Where it Counts

WRITTEN BY: Xuan Pham

Researchers have captured how a new organo-metal compound infiltrates cancer cells and destroys its most vulnerable organelle: the mitochondria.

The organo-metal compound, called FY26, is a rare precious metal known as osmium. It was discovered by scientists at the University of Warwick, who previously reported that the metal seemed to shift the metabolism in ovarian cancer cells. In particular, the metal compound stresses cancer cells to use their defective mitochondria, which is a death sentence for these cells.

"Healthy cells generate their energy in organelles called mitochondria, but cancer cells have defective mitochondria and are forced to generate energy through glycolysis in the cytoplasm. Our new compounds work by attacking the energy balance in cancer cells,” explained Dr. Peter Sadler, a professor a the University of Warwick, and the study’s senior author.

In their latest study, Sadler’s team was able to capture just how FY26 targets cancer cells from the inside. They used X-ray fluorescence to track the compound directly to the mitochondria of cancer cells.

"The advanced nano-focussed x-ray beam at ESRF has not only allowed us to locate the site of action of our novel Organo-Osmium FY26 candidate drug in cancer cells at unprecedented resolution, but also study the movement of natural metals such as zinc and calcium in cells. Such studies open up totally new approaches to drug discovery and treatment,” Dr. Sadler said.

In particular, FY26 is reportedly 49 times more potent than Cisplatin - a common platinum-based chemotherapeutic agent.  "Existing platinum-based cancer treatments often become less effective after the first course, as cancer cells learn how they are being attacked, but our new osmium compound with its different mechanism of action, remains active against cancer cells that have become resistant to drugs such as Cisplatin,” said Sadler.

The team also argue that, in addition to the higher potency and selectivity, osmium-based drugs may be cheaper to produce overall. "Cancer drugs with new mechanisms of actions which can combat resistance and have fewer side-effects are urgently needed,” Sadler noted.

Of note, the compound was only tested in ovarian cancer cells and with much higher doses than would be typically used in a clinical setting. As such, further investigations into how FY26 behaves in live animal systems are important to determine if this drug will be appropriate for cancer patients.

Additional sources: MNT

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 12, 2018
Cancer
NOV 12, 2018
Targeted radiation therapy may provide new hope to children with difficult-to-treat liver cancer
Primary malignant liver tumors are rare in children with an occurrence rate of 1-2% of all childhood cancers. Radical surgical resection of the liver which means the removal of part of the li...
NOV 14, 2018
Immunology
NOV 14, 2018
Reversing T Cell dysfunction in Cancer: Getting the Body to Fight its own Battles
Using the power of the immune system to eliminate cancerous cells has long the been the goal of immuno-oncology. Immune cells naturally recognize, destroy,...
DEC 11, 2018
Cancer
DEC 11, 2018
Biosensors developed that can detect cancer's metastatic ability
Researchers in University of California San Diego School of Medicine have developed a biosensor that can detect whether a cancer cell will spread in the future or not, which will help in deve...
DEC 11, 2018
Immunology
DEC 11, 2018
Penetrating Brain Tumors
A team of researchers reveals potential targets for glioma tumors....
DEC 23, 2018
Drug Discovery
DEC 23, 2018
Super-Drug for Pediatric Leukemia?
In a final study published in Genes & Development, researchers at Northwestern University School of Medicine concluded their discoveries on two success...
FEB 16, 2019
Cell & Molecular Biology
FEB 16, 2019
Using Cellular Barcoding to Understand the Spread of Breast Cancer
Researchers have found that while chemotherapy can reduce the size of a tumor, it may not eliminate all of the cancerous cells....
Loading Comments...